Compile Data Set for Download or QSAR
Report error Found 85 Enz. Inhib. hit(s) with all data for entry = 9034
TargetFibroblast growth factor receptor 4 [460-802](Human)
Nanjing Innocare Pharma Tech

US Patent
LigandPNGBDBM436201(US10590109, Compound 19)
Affinity DataIC50: 10nMAssay Description:FGFR4:The in vitro activity of FGFR4 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HTR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetFibroblast growth factor receptor 4 [460-802](Human)
Nanjing Innocare Pharma Tech

US Patent
LigandPNGBDBM436200(US10590109, Compound 25 | US10590109, Compound 18)
Affinity DataIC50: 10nMAssay Description:FGFR4:The in vitro activity of FGFR4 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HTR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetFibroblast growth factor receptor 4 [460-802](Human)
Nanjing Innocare Pharma Tech

US Patent
LigandPNGBDBM436208(US10590109, Compound 26)
Affinity DataIC50: 10nMAssay Description:FGFR4:The in vitro activity of FGFR4 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HTR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetFibroblast growth factor receptor 4 [460-802](Human)
Nanjing Innocare Pharma Tech

US Patent
LigandPNGBDBM436192(US10590109, Compound 10)
Affinity DataIC50: 10nMAssay Description:FGFR4:The in vitro activity of FGFR4 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HTR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetFibroblast growth factor receptor 4 [460-802](Human)
Nanjing Innocare Pharma Tech

US Patent
LigandPNGBDBM436200(US10590109, Compound 25 | US10590109, Compound 18)
Affinity DataIC50: 10nMAssay Description:FGFR4:The in vitro activity of FGFR4 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HTR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetFibroblast growth factor receptor 4 [460-802](Human)
Nanjing Innocare Pharma Tech

US Patent
LigandPNGBDBM436191(US10590109, Compound 9)
Affinity DataIC50: 10nMAssay Description:FGFR4:The in vitro activity of FGFR4 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HTR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetFibroblast growth factor receptor 4 [460-802](Human)
Nanjing Innocare Pharma Tech

US Patent
LigandPNGBDBM436188(US10590109, Compound 6)
Affinity DataIC50: 10nMAssay Description:FGFR4:The in vitro activity of FGFR4 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HTR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetFibroblast growth factor receptor 4 [460-802](Human)
Nanjing Innocare Pharma Tech

US Patent
LigandPNGBDBM436198(US10590109, Compound 16)
Affinity DataIC50: 10nMAssay Description:FGFR4:The in vitro activity of FGFR4 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HTR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetFibroblast growth factor receptor 4 [460-802](Human)
Nanjing Innocare Pharma Tech

US Patent
LigandPNGBDBM436206(US10590109, Compound 24)
Affinity DataIC50: 10nMAssay Description:FGFR4:The in vitro activity of FGFR4 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HTR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetFibroblast growth factor receptor 4 [460-802](Human)
Nanjing Innocare Pharma Tech

US Patent
LigandPNGBDBM436189(US10590109, Compound 7)
Affinity DataIC50: 10nMAssay Description:FGFR4:The in vitro activity of FGFR4 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HTR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetFibroblast growth factor receptor 4 [460-802](Human)
Nanjing Innocare Pharma Tech

US Patent
LigandPNGBDBM436187(US10590109, Compound 5)
Affinity DataIC50: 10nMAssay Description:FGFR4:The in vitro activity of FGFR4 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HTR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetFibroblast growth factor receptor 4 [460-802](Human)
Nanjing Innocare Pharma Tech

US Patent
LigandPNGBDBM436196(US10590109, Compound 14)
Affinity DataIC50: 10nMAssay Description:FGFR4:The in vitro activity of FGFR4 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HTR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetFibroblast growth factor receptor 4 [460-802](Human)
Nanjing Innocare Pharma Tech

US Patent
LigandPNGBDBM436174(US10590109, Compound 1)
Affinity DataIC50: 10nMAssay Description:FGFR4:The in vitro activity of FGFR4 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HTR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetFibroblast growth factor receptor 4 [460-802](Human)
Nanjing Innocare Pharma Tech

US Patent
LigandPNGBDBM436197(US10590109, Compound 20 | US10590109, Compound 15)
Affinity DataIC50: 10nMAssay Description:FGFR4:The in vitro activity of FGFR4 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HTR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetFibroblast growth factor receptor 4 [460-802](Human)
Nanjing Innocare Pharma Tech

US Patent
LigandPNGBDBM436194(US10590109, Compound 12)
Affinity DataIC50: 10nMAssay Description:FGFR4:The in vitro activity of FGFR4 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HTR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetFibroblast growth factor receptor 4 [460-802](Human)
Nanjing Innocare Pharma Tech

US Patent
LigandPNGBDBM436204(US10590109, Compound 23)
Affinity DataIC50: 55nMAssay Description:FGFR4:The in vitro activity of FGFR4 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HTR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetFibroblast growth factor receptor 4 [460-802](Human)
Nanjing Innocare Pharma Tech

US Patent
LigandPNGBDBM436193(US10590109, Compound 11)
Affinity DataIC50: 55nMAssay Description:FGFR4:The in vitro activity of FGFR4 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HTR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetFibroblast growth factor receptor 4 [460-802](Human)
Nanjing Innocare Pharma Tech

US Patent
LigandPNGBDBM436197(US10590109, Compound 20 | US10590109, Compound 15)
Affinity DataIC50: 55nMAssay Description:FGFR4:The in vitro activity of FGFR4 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HTR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetFibroblast growth factor receptor 4 [460-802](Human)
Nanjing Innocare Pharma Tech

US Patent
LigandPNGBDBM436184(US10590109, Compound 3)
Affinity DataIC50: 55nMAssay Description:FGFR4:The in vitro activity of FGFR4 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HTR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetFibroblast growth factor receptor 4 [460-802](Human)
Nanjing Innocare Pharma Tech

US Patent
LigandPNGBDBM436195(US10590109, Compound 13)
Affinity DataIC50: 55nMAssay Description:FGFR4:The in vitro activity of FGFR4 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HTR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetFibroblast growth factor receptor 4 [460-802](Human)
Nanjing Innocare Pharma Tech

US Patent
LigandPNGBDBM436185(US10590109, Compound 4)
Affinity DataIC50: 550nMAssay Description:FGFR4:The in vitro activity of FGFR4 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HTR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetFibroblast growth factor receptor 4 [460-802](Human)
Nanjing Innocare Pharma Tech

US Patent
LigandPNGBDBM436183(US10590109, Compound 2)
Affinity DataIC50: 550nMAssay Description:FGFR4:The in vitro activity of FGFR4 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HTR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetFibroblast growth factor receptor 4 [460-802](Human)
Nanjing Innocare Pharma Tech

US Patent
LigandPNGBDBM436205(US10590109, Compound 22)
Affinity DataIC50: 550nMAssay Description:FGFR4:The in vitro activity of FGFR4 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HTR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetFibroblast growth factor receptor 4 [460-802](Human)
Nanjing Innocare Pharma Tech

US Patent
LigandPNGBDBM436190(US10590109, Compound 8)
Affinity DataIC50: 550nMAssay Description:FGFR4:The in vitro activity of FGFR4 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HTR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetFibroblast growth factor receptor 4 [460-802](Human)
Nanjing Innocare Pharma Tech

US Patent
LigandPNGBDBM436199(US10590109, Compound 17)
Affinity DataIC50: 550nMAssay Description:FGFR4:The in vitro activity of FGFR4 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HTR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetFibroblast growth factor receptor 4 [460-802](Human)
Nanjing Innocare Pharma Tech

US Patent
LigandPNGBDBM436203(US10590109, Compound 21)
Affinity DataIC50: 550nMAssay Description:FGFR4:The in vitro activity of FGFR4 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HTR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetFibroblast growth factor receptor 1 [308-731](Human)
Nanjing Innocare Pharma Tech

US Patent
LigandPNGBDBM436208(US10590109, Compound 26)
Affinity DataIC50: 1.00E+3nMAssay Description:FGFR1: The in vitro activity of FGFR1 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HT...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetFibroblast growth factor receptor 3 [399-806](Human)
Nanjing Innocare Pharma Tech

US Patent
LigandPNGBDBM436208(US10590109, Compound 26)
Affinity DataIC50: 1.00E+3nMAssay Description:FGFR3: The in vitro activity of FGFR3 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HT...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetFibroblast growth factor receptor 2 [400-821](Human)
Nanjing Innocare Pharma Tech

US Patent
LigandPNGBDBM436208(US10590109, Compound 26)
Affinity DataIC50: 1.00E+3nMAssay Description:FGFR2: The in vitro activity of FGFR2 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HT...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetFibroblast growth factor receptor 1 [308-731](Human)
Nanjing Innocare Pharma Tech

US Patent
LigandPNGBDBM436200(US10590109, Compound 25 | US10590109, Compound 18)
Affinity DataIC50: 1.00E+3nMAssay Description:FGFR1: The in vitro activity of FGFR1 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HT...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetFibroblast growth factor receptor 3 [399-806](Human)
Nanjing Innocare Pharma Tech

US Patent
LigandPNGBDBM436200(US10590109, Compound 25 | US10590109, Compound 18)
Affinity DataIC50: 1.00E+3nMAssay Description:FGFR3: The in vitro activity of FGFR3 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HT...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetFibroblast growth factor receptor 2 [400-821](Human)
Nanjing Innocare Pharma Tech

US Patent
LigandPNGBDBM436200(US10590109, Compound 25 | US10590109, Compound 18)
Affinity DataIC50: 1.00E+3nMAssay Description:FGFR2: The in vitro activity of FGFR2 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HT...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetFibroblast growth factor receptor 1 [308-731](Human)
Nanjing Innocare Pharma Tech

US Patent
LigandPNGBDBM436206(US10590109, Compound 24)
Affinity DataIC50: 1.00E+3nMAssay Description:FGFR1: The in vitro activity of FGFR1 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HT...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetFibroblast growth factor receptor 3 [399-806](Human)
Nanjing Innocare Pharma Tech

US Patent
LigandPNGBDBM436206(US10590109, Compound 24)
Affinity DataIC50: 1.00E+3nMAssay Description:FGFR3: The in vitro activity of FGFR3 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HT...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetFibroblast growth factor receptor 2 [400-821](Human)
Nanjing Innocare Pharma Tech

US Patent
LigandPNGBDBM436206(US10590109, Compound 24)
Affinity DataIC50: 1.00E+3nMAssay Description:FGFR2: The in vitro activity of FGFR2 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HT...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetFibroblast growth factor receptor 1 [308-731](Human)
Nanjing Innocare Pharma Tech

US Patent
LigandPNGBDBM436184(US10590109, Compound 3)
Affinity DataIC50: 1.00E+3nMAssay Description:FGFR1: The in vitro activity of FGFR1 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HT...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetFibroblast growth factor receptor 1 [308-731](Human)
Nanjing Innocare Pharma Tech

US Patent
LigandPNGBDBM436185(US10590109, Compound 4)
Affinity DataIC50: 1.00E+3nMAssay Description:FGFR1: The in vitro activity of FGFR1 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HT...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetFibroblast growth factor receptor 1 [308-731](Human)
Nanjing Innocare Pharma Tech

US Patent
LigandPNGBDBM436174(US10590109, Compound 1)
Affinity DataIC50: 1.00E+3nMAssay Description:FGFR1: The in vitro activity of FGFR1 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HT...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetFibroblast growth factor receptor 1 [308-731](Human)
Nanjing Innocare Pharma Tech

US Patent
LigandPNGBDBM436183(US10590109, Compound 2)
Affinity DataIC50: 1.00E+3nMAssay Description:FGFR1: The in vitro activity of FGFR1 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HT...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetFibroblast growth factor receptor 2 [400-821](Human)
Nanjing Innocare Pharma Tech

US Patent
LigandPNGBDBM436192(US10590109, Compound 10)
Affinity DataIC50: 1.00E+3nMAssay Description:FGFR2: The in vitro activity of FGFR2 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HT...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetFibroblast growth factor receptor 1 [308-731](Human)
Nanjing Innocare Pharma Tech

US Patent
LigandPNGBDBM436192(US10590109, Compound 10)
Affinity DataIC50: 1.00E+3nMAssay Description:FGFR1: The in vitro activity of FGFR1 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HT...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetFibroblast growth factor receptor 3 [399-806](Human)
Nanjing Innocare Pharma Tech

US Patent
LigandPNGBDBM436192(US10590109, Compound 10)
Affinity DataIC50: 1.00E+3nMAssay Description:FGFR3: The in vitro activity of FGFR3 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HT...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetFibroblast growth factor receptor 2 [400-821](Human)
Nanjing Innocare Pharma Tech

US Patent
LigandPNGBDBM436191(US10590109, Compound 9)
Affinity DataIC50: 1.00E+3nMAssay Description:FGFR2: The in vitro activity of FGFR2 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HT...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetFibroblast growth factor receptor 1 [308-731](Human)
Nanjing Innocare Pharma Tech

US Patent
LigandPNGBDBM436191(US10590109, Compound 9)
Affinity DataIC50: 1.00E+3nMAssay Description:FGFR1: The in vitro activity of FGFR1 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HT...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetFibroblast growth factor receptor 3 [399-806](Human)
Nanjing Innocare Pharma Tech

US Patent
LigandPNGBDBM436191(US10590109, Compound 9)
Affinity DataIC50: 1.00E+3nMAssay Description:FGFR3: The in vitro activity of FGFR3 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HT...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetFibroblast growth factor receptor 1 [308-731](Human)
Nanjing Innocare Pharma Tech

US Patent
LigandPNGBDBM436189(US10590109, Compound 7)
Affinity DataIC50: 1.00E+3nMAssay Description:FGFR1: The in vitro activity of FGFR1 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HT...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetFibroblast growth factor receptor 1 [308-731](Human)
Nanjing Innocare Pharma Tech

US Patent
LigandPNGBDBM436190(US10590109, Compound 8)
Affinity DataIC50: 1.00E+3nMAssay Description:FGFR1: The in vitro activity of FGFR1 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HT...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetFibroblast growth factor receptor 1 [308-731](Human)
Nanjing Innocare Pharma Tech

US Patent
LigandPNGBDBM436187(US10590109, Compound 5)
Affinity DataIC50: 1.00E+3nMAssay Description:FGFR1: The in vitro activity of FGFR1 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HT...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetFibroblast growth factor receptor 1 [308-731](Human)
Nanjing Innocare Pharma Tech

US Patent
LigandPNGBDBM436188(US10590109, Compound 6)
Affinity DataIC50: 1.00E+3nMAssay Description:FGFR1: The in vitro activity of FGFR1 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HT...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

TargetFibroblast growth factor receptor 2 [400-821](Human)
Nanjing Innocare Pharma Tech

US Patent
LigandPNGBDBM436196(US10590109, Compound 14)
Affinity DataIC50: 1.00E+3nMAssay Description:FGFR2: The in vitro activity of FGFR2 was determined by assaying the phosphorylation level of the substrate in the kinase reaction, by means of an HT...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2020
Entry Details
US Patent

Displayed 1 to 50 (of 85 total ) | Next | Last >>
Jump to: